These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30131337)

  • 1. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
    Rösener NS; Gremer L; Reinartz E; König A; Brener O; Heise H; Hoyer W; Neudecker P; Willbold D
    J Biol Chem; 2018 Oct; 293(41):15748-15764. PubMed ID: 30131337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
    König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
    J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustering of human prion protein and α-synuclein oligomers requires the prion protein N-terminus.
    Rösener NS; Gremer L; Wördehoff MM; Kupreichyk T; Etzkorn M; Neudecker P; Hoyer W
    Commun Biol; 2020 Jul; 3(1):365. PubMed ID: 32647130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
    Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
    FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
    Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain.
    Zou WQ; Xiao X; Yuan J; Puoti G; Fujioka H; Wang X; Richardson S; Zhou X; Zou R; Li S; Zhu X; McGeer PL; McGeehan J; Kneale G; Rincon-Limas DE; Fernandez-Funez P; Lee HG; Smith MA; Petersen RB; Guo JP
    J Biol Chem; 2011 Apr; 286(17):15095-105. PubMed ID: 21393248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and Toxicity.
    Pagano K; Galante D; D'Arrigo C; Corsaro A; Nizzari M; Florio T; Molinari H; Tomaselli S; Ragona L
    Mol Neurobiol; 2019 Mar; 56(3):1957-1971. PubMed ID: 29981054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein.
    Madhu P; Mukhopadhyay S
    ACS Chem Neurosci; 2020 Jan; 11(1):86-98. PubMed ID: 31808343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a
    Younan ND; Chen KF; Rose RS; Crowther DC; Viles JH
    J Biol Chem; 2018 Aug; 293(34):13090-13099. PubMed ID: 29887525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.
    Bove-Fenderson E; Urano R; Straub JE; Harris DA
    J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers.
    Younan ND; Sarell CJ; Davies P; Brown DR; Viles JH
    FASEB J; 2013 May; 27(5):1847-58. PubMed ID: 23335053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
    Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.
    Smith LM; Strittmatter SM
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 27940601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues.
    Chen S; Yadav SP; Surewicz WK
    J Biol Chem; 2010 Aug; 285(34):26377-83. PubMed ID: 20576610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.
    Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C
    Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein.
    Balducci C; Beeg M; Stravalaci M; Bastone A; Sclip A; Biasini E; Tapella L; Colombo L; Manzoni C; Borsello T; Chiesa R; Gobbi M; Salmona M; Forloni G
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2295-300. PubMed ID: 20133875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.